Hong Kong stocks rise as investors cheer COVID-19 vaccine progress

Techtronic Industries Co

10/11/2020 08:37

* HK->Shanghai Connect daily quota used 5.6%, Shanghai->HK
daily
quota used -0.3%
    * HSI +1.1%, HSCE -0.4%, CSI300 -0.6%
    * FTSE China A50 -0.2%

    Nov 10 (Reuters) - Hong Kong stocks rose on Tuesday, in line
with gains in other parts of Asian markets, as investors cheered
progress in the development of a COVID-19 vaccine. 
    ** At the close of trade, the Hang Seng index  .HSI  was up
285.31 points, or 1.1%, at 26,301.48. The Hang Seng China
Enterprises index  .HSCE  fell 0.43% to 10,586.89.
    ** The sub-index of the Hang Seng tracking energy shares
 .HSCIE  rose 9.3%, while the IT sector  .HSCIIT  dipped 5.98%,
the financial sector  .HSNF  ended 3.31% higher and the property
sector rose 4.8%.
    ** The top gainer on the Hang Seng was CNOOC Ltd  0883.HK ,
which gained 13.96%, while the biggest loser was Techtronic
Industries Co Ltd  0669.HK , which fell 9.79%. 
    ** Pfizer Inc's  PFE.N  experimental COVID-19 vaccine is
more than 90% effective based on initial trial results, the
drugmaker said on Monday, a major victory in the war against a
virus that has killed over a million people and battered the
global economy.  urn:newsml:reuters.com:*:nL1N2HV0TR 
    ** But tech shares tracked overnight weakness on the Nasdaq
Composite  .IXIC , as companies that outperformed during the
pandemic fell on news of Pfizer's vaccine progress. 
    ** The Hang Seng tech index  .HSTECH  tumbled 5.2%, posting
its worst day since July 16. 
    ** Around the region, MSCI's Asia ex-Japan stock index
 .MIAPJ0000PUS  was firmer by 0.92%, while Japan's Nikkei index
 .N225  closed up 0.26%.
    ** The yuan  CNY=CFXS  was quoted at 6.6087 per U.S. dollar
at 0820 GMT, 0.29% firmer than the previous close of 6.628. 
    ** At close, China's A-shares were trading at a premium of
40.64% over Hong Kong-listed H-shares.

 (Reporting by the Shanghai Newsroom; Editing by Rashmi Aich)
 ((luoyan.liu@thomsonreuters.com; Reuters Messaging:
luoyan.liu.thomsonreuters.com@reuters.net))